4basebio (LON:4BB) Insider Amy Walker Buys 1,863 Shares

4basebio PLC (LON:4BB) insider Amy Walker acquired 1,863 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The shares were purchased at an average cost of GBX 509 per share, for a total transaction of £9,482.67.

4basebio Trading Up 4.9%

LON 4BB opened at GBX 509 on Friday. The company has a quick ratio of 3.52, a current ratio of 2.73 and a debt-to-equity ratio of 201.47. 4basebio PLC has a twelve month low of GBX 420 and a twelve month high of GBX 1,150. The company has a market cap of £78.82 million, a price-to-earnings ratio of -5.14 and a beta of 1.09. The business’s fifty day moving average is GBX 496.71 and its 200 day moving average is GBX 579.35.

4basebio (LON:4BB) last released its quarterly earnings data on Wednesday, May 20th. The company reported GBX (1.09) earnings per share for the quarter. The company had revenue of GBX 169 million during the quarter. As a group, sell-side analysts expect that 4basebio PLC will post -3.43 EPS for the current fiscal year.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.